NSE filing, NSE: AUROPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Aurobindo Pharma Ltd: key numbers
- Share price
- ₹1,799.00
- Market cap
- ₹1,04,486 Cr
- Revenue (annual)
- ₹33,653 Cr
- Net profit (annual)
- ₹3,505 Cr
- P/E (TTM)
- 24.8×Sector 49.0×
- Promoter holding
- 51.88%+0.00% QoQ
- FII holding
- 17.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aurobindo Pharma Ltd
All →Aurobindo Pharma Business Update
Aurobindo's subsidiary Apitoria's Unit-VI received a USFDA EIR classifying it as Voluntary Action Indicated, and the inspection is now closed. No monetary penalty is stated.
Aurobindo Pharma Business Update
Aurobindo Pharma disclosed that US FDA classified its Lannett facility inspection as Official Action Indicated (OAI). The company states there is no quantifiable financial or operational impact.
Aurobindo Pharma Acquisition Worth ₹29 Cr
Aurobindo's subsidiary Auropharm Overseas will buy 100% of Auro Pharma LLC, a Russian step-down subsidiary, for about Rs 29 crore cash. It is an internal group reorganisation.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Aurobindo Pharma Management Change
Aurobindo Pharma's board approved reappointing independent director Mangalam Ramasubramanian Kumar for a second five-year term from April 1, 2027. Shareholder approval by postal ballot is required.
- Execution
- Five years from April 1, 2027
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Aurobindo Pharma Acquisition
Aurobindo Pharma announced a board-approved proposal to merge two wholly owned subsidiaries, Auroactive Pharma into Apitoria Pharma, via NCLT scheme. No cash consideration; the share-exchange ratio issues 23,95,900 shares of Apitoria.
Other annual general meeting announcements
All →Priority Jewels Annual General Meeting
Priority Jewels will hold its 19th AGM via video conferencing on December 14, 2026. Agenda includes ESOP ratifications, a director reappointment and charges for document service.
Avalon Technologies Annual General Meeting
Avalon Technologies held its EGM on November 21, 2026, transacting an articles alteration and a preferential warrant issue. Voting results and scrutinizer report to follow.
Wealth First Portfolio Managers Annual General Meeting
Wealth First held its EGM on November 21, 2026, by video conference. Members considered a non-cash preferential share issue and a related-party transaction.
Sakuma Exports Annual General Meeting
Sakuma Exports Limited's EGM on 21 November 2026 lapsed for want of quorum and was adjourned. The meeting is rescheduled to 28 November 2026 by video conference.
Suprajit Engineering Annual General Meeting
Suprajit Engineering seeks shareholder approval via postal ballot to appoint Dr. Steffen Berns as Independent Director. E-voting closes December 22, 2026.
Zetwerk Manufacturing Businesses Annual General Meeting
Zetwerk Manufacturing issued a postal ballot notice with five special resolutions on ESOP amendments and articles alteration. Voting closes 20 December 2026.